P11: USING ULTRASOUND TO CHARACTERISE AND HELP MANAGE OVARIAN MASSES: EXPERIENCE OF USING THE IOTA ADNEX MODEL AND SIMPLE RULES
Objectives: The purpose of our study was to compare the diagnostic accuracy of two IOTA models -ADNEX and LR2 -and SA in predicting histopathological result of adnexal masses. Methods: This is a prospective ongoing study at Poznan University Hospital. From September 2016 till March 2017 90 ovarian masses in women undergoing surgery were analysed. 65% women were premenopausal and 35% were postmenopausal. Adnexal lesions were evaluated with transvaginal ultrasound according to IOTA rules and definitions. Images were collected by 5 fellows and interpreted by 2 expert sonographers. Serum concentration of CA 125 was measured prior to surgery. The definitive diagnosis was determined on the basis of the histopathological outcome of excised lesions. Results: Mean age of women included in the study was 42,90 +/-15,25 years. Of the 90 masses 16,6% were malignant, 80% benign and 3,3% borderline. The AUC of the ADNEX model for the mere discrimination between benign and malignant tumours was 0,92 (95% CI 0,90-0,96). AUC for the subtypes of malignancy ranged between 0,76 (95% CI 0,69-0,82) and 0,82 (95% CI 0,79-0,84). The AUC's of the LR2 model and SA were 0,85 (95% CI 0,80-0,90) and 0,93 (95% CI 0,91-0,96), respectively. Discriminative performance was also assessed by computing sensitivity, specificity, positive and negative likehood ratio, positive and negative predictive value for the following cut-offs for the risk of malignancy: 5%, 10% and 15%. Sensitivity of the ADNEX model was 90,9% (95% CI 88,6%-92,3%) for all cut-offs while its specificity was the highest for the cut-off of >15%. In the LR2 model the optimal combination of highest sensitivity and specificity [86,8% (95% CI 83,2%-89,8%) and 59,2%] was obtained for the cut-off of >10%. Conclusions: SA was moderately superior to the ADNEX model in discriminating malignant and benign ovarian masses. ADNEX model showed high sensitivity in discriminating between tumour subgroups. LR2 model was less accurate than ADNEX and SA in pre-surgical evaluation of malignancy.
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Objectives: To analyse the performance of IOTA ADNEX model for the differentiation of histological subtypes of borderline ovarian tumours (BOT). Methods: Retrospective analysis of ultrasound (US) dataset of patients diagnosed with BOT on the final histology was done at the tertiary oncology centre in the period of [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] . The IOTA ADNEX model (web application) was used to calculate the absolute risk (AR) and the relative risk (RR) for the mass being BOT. Results: 57 (72.2%) of patients were diagnosed with serous BOTs (s_BOTs) and 22 (27.8%) with mucinous BOTs (m_BOTs). Without CA-125, according to AR, the ADNEX correctly classified 37 (64.9%) serous and 12 (54.5%) mucinous BOTs with no difference between the groups. According to RR, the test correctly differentiated 44 (77.2%) serous BOTs and 15 (68.2%) mucinous BOTs (p=0.409 between the groups). When tumours were classified according to RR, the performance of ADNEX increased by 35% and 30% in s_BOTs and m_BOTs groups respectively (p<0.05). When CA-125 was added, according to AR, 35 (68.6%) of s_BOTs and 11 (57.9%) m_BOTs were correctly classified. According to RR, 41 (80.4%) of s_BOTs and 14 (73.7%) of m_BOTs were classified correctly. The performance of ADNEX model increased by 37.5% in both groups when differentiating tumours according to RR vs. AR (p<0.05). The mean AR and RR was significantly higher in s_BOTs compared to m_BOTs group (30.8% vs. 18.1% and 4.89 vs. 2.88, respectively; p=0.002) . However, when CA-125 was added, the difference of mean AR (29.4% vs. 21.4%) and RR (4.67 vs. 3.39) slightly decreased and was no longer significant (p=0.106). Conclusions: IOTA ADNEX model works well in differentiating BOTs of different histological subtypes. The performance is better when tumours are differentiated according to the RR and the values of risk are higher in serous BOTs compared to mucinous ones.
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